Shannon McDonough

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

Scott Kopetz, Katherine A. Guthrie, Van K. Morris et al. · Journal of Clinical Oncology · 2020 · 381 citations · Full text

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip et al. · Journal of Clinical Oncology · 2019 · 314 citations · Full text

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy

Vincent Chung, Shannon McDonough, Philip A. Philip et al. · JAMA Oncology · 2016 · 173 citations · Full text

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518

James C. Yao, Katherine A. Guthrie, César A. Moran et al. · Journal of Clinical Oncology · 2017 · 161 citations · Full text

Immunology, Pathology, Pharmacotherapy +16

Randomized trial of irinotecan and cetuximab with or without vemurafenib in <i>BRAF</i>-mutant metastatic colorectal cancer (SWOG 1406).

Scott Kopetz, Shannon McDonough, Van K. Morris et al. · Journal of Clinical Oncology · 2017 · 107 citations

Gastrointestinal Oncology, Medicine, Metronomic Therapy +15